New scientific approaches to smoking cessation may not only extinguish additional tobacco sales from supermarket courtesy counters, but may also cut into sales of all the nicotine patches, gums and lozenges currently offered in the pharmacy. Several initiatives are nearing reality. Pfizer's Varenicline is a pill designed to deactivate the nicotinic receptor in the patient's brain to reduce both the severity of cravings and nicotine withdrawal symptoms. Kate Robins, director of media ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Why Register for FREE?
Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick. What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
Attention Paid Print Subscribers: While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.